Role of high sensitive C-reactive protein as a marker in assessing severity of asthma

Omparkash Dhania; Reshu Tewari; Anurag Bajpai

doi:10.53730/ijhs.v6nS4.5704

Authors

Omparkash Dhania Associate Professor, TB & Respiratory Medicine, NC Medical College, Israna, Panipat
Reshu Tewari Associate Professor, Department of Biochemistry, NC Medical College and Hospital, Israna, Panipat
Anurag Bajpai Professor, Department of Pharmacology, NC Medical College and Hospital, Israna, Panipat

Keywords:

asthma, high sensitive C-reactive protein (hs-CRP), CRP, pulmonary function tests

Abstract

Increased serum high sensitive C-reactive protein (hs-CRP) in asthma and its association with disease severity has been investigated in many studies. This study aimed to determine serum hs-CRP status in asthma versus healthy controls and to examine its ability in predicting asthma control. This is a comparative-descriptive and observational study was carried out in the TB & Respiratory Medicine, N.C Medical College and Hospital over a period of 6 months. Total 70 patients (both old and newly diagnosed cases) were selected for the study for case group patients were on maintenance treatment including inhaled corticosteroids and bronchodilators according to the guideline treatment of asthma. In our present study, a total of 70 patients were included out of which 38 (57.4%) were males. In our study, most of the patients were 51-70 years i.e., 38 out of 70 (54.2%), followed by 31-50. The mean hs CRP of Case group patients are 4.31±1.46 and in control group patients 0.83±0.07. Pulmonary function test using Spirometer was s done in all the patients (case and control). The FEV1 values are compared against hsCRP values. Statistical significance is assessed using Spearman’s correlation. Case group patients showing highly significant negative correlation of hsCRP with FEV1.

Downloads

Download data is not yet available.

References

Wouters EF. The systemic face of airway diseases: the role of C-reactive protein. Eur Respir J 2006; 27: 877-9.

Fahy JV, Corry DB, Boushey HA. Airway inflammation and remodeling in asthma. Cur Opin Pulm Med 2000; 6: 15-20.

Riccioni G, Di Ilio C, and D’ Orazio N. Review: Pharmacological treatment of airway remodeling: inhaled corticosteroids or antileukotrienes? Ann Clin Lab Sci 2004; 34: 138-42.

Kasayama S, Tanemura M, Koga M, et al. Asthma is an independent risk for elevation of plasma C-reactive protein levels. Clin Chim Acta 2009; 399: 79-82.

Deraz TE, Kamel TB, El-Kerdany TA, El- Ghazoly HM. High-sensitivity C reactive protein as a biomarker for grading of childhood asthma in relation to clinical classification, induced sputum cellularity, and spirometry. Pediatr Pulmonol 2012; 47: 220-5.

Zietkowski Z, Tomasiak-Lozowska MM, Skiepko R, et al. High-sensitivity C-reactive protein in the exhaled breath condensate and serum in stable and unstable asthma. Respir Med 2009; 103: 379-85.

Halvani A, Tahghighi F, Nadooshan HH. Evaluation of correlation between airway and serum inflammatory markers in asthmatic patients. Lung India 2012; 29: 143-6.

Popov TA, Petrova D, Kralimarkova TZ, et al. Real life clinical study design supporting the effectiveness of extra-fine inhaled beclomethasone/formoterol at the level of small airways of asthmatics. Pulm Pharmacol Ther 2013; 26: 624-9.

Sigari N, Ghasri H. Correlation between hs-CRP and asthma control indices. Tanaffos 2013; 12: 44-8.

Heidari B. C-reactive protein and other markers of inflammation in hemodialysis patients. Caspian J Intern Med 2013; 4: 611-16.

Shimoda T, Obase Y, Kishikawa R, Iwanaga T. Serum high-sensitivity C-reactive protein can be an airway inflammation predictor in bronchial asthma. Allergy Asthma Proc 2015; 36: e23-8

Firouzjahi A, Monadi M, Karimpoor F, et al. Serum C-reactive protein level and distribution in chronic obstructive pulmonary disease versus healthy controls: a case-control study from Iran. Inflammation 2013; 36: 1122-8.

Ramirez D, Patel P, Casillas A, et al. Assessment of high-sensitivity C-reactive protein as a marker of airway inflammation in asthma. Ann Allergy Asthma Immunol 2010; 104: 485-9.

Monadi M, Javadian Y, Cheraghi M, Heidari B, Amiri M. Impact of treatment with inhaled corticosteroids on bone mineral density of patients with asthma: related with age. Osteoporos Int 2015; 26: 2013-8.

Ahmadi-Abhari S, Kaptoge S, Luben RN, Wareham NJ, Khaw KT. Longitudinal association of C-reactive protein and lung function over 13 years: The EPIC-Norfolk study. Am J Epidemiol 2014; 179: 48-56.

Takemura M, Matsumoto H, Niimi A, Ueda T, Matsuoka H, Yamaguchi M, et al. High sensitivity C-reactive protein in asthma. Eur Respir J. 2006; 27(5):908–12.

Sahoo RC, Acharya PR, Noushad TH, Anand R, Acharya VK, Sahu KR, et al. A Study of High-Sensitivity C - reactive protein in Bronchial Asthma. Indian J Chest Dis Allied Sci. 2009; 51(4):213–6.

Menon B, Nima G, Kaur DV, C. Reactive protein as a marker of asthma control. Int J Basic App Med Sci. 2013; 3(3):114–19.

Qian FH, Zhang Q, Zhou LF, Liu H, Huang M, Zhang XL, et al. High-sensitivity C-reactive protein: a predicative marker in severe asthma. Respir. 2008; 13(5):664–9.

Krishnamoorthy S, Maamidi S, Balasubramanian N, Karthikeyan R, Kaza A. Effect of inhaled corticosteroids on systemic inflammation in asthma. Perspect Clin Res. 2014; 5(2):75–9.

Kasem AH. High sensitivity C - reactive protein: Its correlation with sputum cell counts in Bronchial asthma. J Respir Med. 2009; 103:1878–84.

Ducharme FM, Dell SD, Radhakrishnan D, Grad RM, Watson WT, Yang CL, Zelman M. Diagnosis and management of asthma in preschoolers: a Canadian Thoracic Society and Canadian Pediatric Society position paper. Can Respir J. 2015; 22(3):135–43.

Aaron SD, Vandemheen KL, FitzGerald JM, Ainslie M, Gupta S, Lemière C, Field SK, McIvor RA, Hernandez P, Mayers I, Mulpuru S, Alvarez GG, Pakhale S, Mallick R, Boulet LP, Canadian Respiratory Research Network. Reevaluation of diagnosis in adults with physician-diagnosed asthma. JAMA. 2017; 317(3):269–79.

Büyüköztürk S, Gelincik AA, Genc¸ S, Koc¸ak H, Oneriyidogan Y, Erden S, et al. Acute phase reactants in allergic airway disease. Tohoku J Exp Med. 2004; 204:209-13.

Ramirez D, Patel P, Casillas A, Cotelingam J, Boggs P, Bahna SL. Assessment of high-sensitivity C-reactive protein as a marker of airway inflammation in asthma. Ann Allergy Asthma Immunol. 2010; 104:485-9.

Kim MH, Kim SH, Kang HR, Park HW, Chang YS, Kim DH, et al. High-sensitivity C-reactive protein as a marker of bronchial hyperresponsiveness and lung function. J Asthma Allergy Clin Immunol. 2009; 29:112-6.